- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Respiratory syncytial virus infection (RSV), is a common respiratory virus that causes infections of the lungs and respiratory tract. It is very common in children but can also infect adults. Usually, this virus causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults, people with heart problems as well as a weak immune system.
Showing all 5 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
04/2019 |
391,50 € |
||
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
06/2019 |
391,50 € |
||
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
10/2019 |
391,50 € |
||
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
02/2020 |
391,50 € |
||
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
08/2020 |
391,50 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin